PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) EBIT: Rp Mil (TTM As of . 20)


ISX:DGNS PT Diagnos Laboratorium Utama Tbk ISX:DGNS
19 GF Score
Price Rp226.00
! 1 Warning Sign
View Full Analysis

What is PT Diagnos Laboratorium Utama Tbk EBIT?

PT Diagnos Laboratorium Utama Tbk ISX:DGNS -3.42% 19 EBIT is Rp Mil as of . 20. GuruFocus rates ISX:DGNS with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

PT Diagnos Laboratorium Utama Tbk's earnings before interest and taxes (EBIT) for the six months ended in . 20 was Rp0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Diagnos Laboratorium Utama Tbk's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Diagnos Laboratorium Utama Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Diagnos Laboratorium Utama Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/310750.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diagnos Laboratorium Utama Tbk EBIT Related Terms

PT Diagnos Laboratorium Utama Tbk EBIT Historical Data

* Premium members only.

The historical data trend for PT Diagnos Laboratorium Utama Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diagnos Laboratorium Utama Tbk EBIT Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
EBIT

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
EBIT

ISX:DGNS vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Diagnos Laboratorium Utama Tbk EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT falls into.


ISX:DGNS
19GF Score
PT Diagnos Laboratorium Utama Tbk ISX:DGNS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Diagnos Laboratorium Utama Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was Rp Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of Rp Mil mean?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a EBIT of Rp Mil as of . 20. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Diagnos Laboratorium Utama Tbk.
Is PT Diagnos Laboratorium Utama Tbk's EBIT too high?
PT Diagnos Laboratorium Utama Tbk's current EBIT is Rp Mil. Overall, PT Diagnos Laboratorium Utama Tbk has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does PT Diagnos Laboratorium Utama Tbk's EBIT compare to TMO and DHR?
PT Diagnos Laboratorium Utama Tbk's EBIT of Rp Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Diagnos Laboratorium Utama Tbk. PT Diagnos Laboratorium Utama Tbk's current EBIT is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diagnos Laboratorium Utama Tbk stock overvalued right now?
PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) has a current EBIT of Rp Mil. The current EBIT is Rp Mil. PT Diagnos Laboratorium Utama Tbk's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For PT Diagnos Laboratorium Utama Tbk (ISX:DGNS), the current EBIT is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diagnos Laboratorium Utama Tbk Business Description

Address Jl. Cikditiro No. 11 A, B, C, Gedung Graha Anam Lantai 2, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Diagnos Laboratorium Utama Tbk operates in the field of Health Support Services and Private Clinic Activities. It provides health support service activities managed by both the government and the private sector, such as health laboratories in the form of X-Ray Laboratories, and other diagnostic imaging centers, as well as blood testing, private clinics, pharmaceutical warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other medical support services. Its products and services include Clinical Pathology Laboratory, Anatomical Pathology Laboratory, Genomics Laboratory, Homecare Health Services, Corporate Health Services, Microbiology Laboratory, and Research Services.
19GF Score

Get the complete analysis for ISX:DGNS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp226.00
Price